首页> 美国卫生研究院文献>Marine Drugs >Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery
【2h】

Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery

机译:海洋生物中的信号转导和转录(STAT)调节网络激活剂:从生理观察到海洋药物发现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Part of our ocean’s richness comes from its extensive history of supporting life, resulting in a highly diverse ecological system. To date, over 250,000 species of marine organisms have been identified, but it is speculated that the actual number of marine species exceeds one million, including several hundreds of millions of species of marine microorganisms. Past studies suggest that approximately 70% of all deep-sea microorganisms, gorgonians, and sea sponges produce secondary metabolites with anti-cancer activities. Recently, novel FDA-approved drugs derived from marine sponges have been shown to reduce metastatic breast cancer, malignant lymphoma, and Hodgkin’s disease. Despite the fact that many marine natural products have been shown to possess a good inhibition potential against most of the cancer-related cell signaling pathways, only a few marine natural products have been shown to target JAK/STAT signaling. In the present paper, we describe the JAK/STAT signaling pathways found in marine organisms, before elaborating on the recent advances in the field of STAT inhibition by marine natural products and the potential application in anti-cancer drug discovery.
机译:我们海洋的丰富性部分来自其丰富的生命维持历史,从而形成了高度多样化的生态系统。迄今为止,已经鉴定出超过25万种海洋生物,但据推测,实际的海洋生物种类已超过一百万,其中包括数亿种海洋微生物。过去的研究表明,所有深海微生物,高哥氏菌和海海绵中约有70%产生具有抗癌活性的次生代谢产物。最近,已经证明,由FDA批准的源自海洋海绵的新型药物可减少转移性乳腺癌,恶性淋巴瘤和霍奇金氏病。尽管事实表明,许多海洋天然产物对大多数与癌症相关的细胞信号通路均具有良好的抑制潜力,但仅显示出少数海洋天然产物靶向JAK / STAT信号。在本文中,我们先介绍在海洋生物中发现的JAK / STAT信号通路,然后再详细介绍海洋天然产物抑制STAT的最新进展以及在抗癌药物发现中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号